| Application no. and date | 17158990.6 (espacenet) (Federated) (European Patent Register), 20110511 | | Patent/reg. no. and date | DK/EP 3195880, 20191127 | | Publication date | 20170726 | | Priority no. and date | US 334986 P, 20100514 | | EP pub. no. and date |
EP 3195880 20170726 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | | Applicant ref. no. | V47066DK00 | | Inventor | OSSLUND, Timothy, D., 475 Vista Montana
Camarillo, CA 93010, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/12 (2006.01) , C07K 16/22 (2006.01) | | Title | Højkoncentrerede anti-sclerostin-antistofformuleringer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
